Published in Transl Psychiatry on February 21, 2012
Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biol Psychiatry (2013) 0.98
C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry (2015) 0.90
Systems biology, bioinformatics, and biomarkers in neuropsychiatry. Front Neurosci (2012) 0.89
Impaired metabolic reactivity to oxidative stress in early psychosis patients. Schizophr Bull (2014) 0.85
Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia. Innov Clin Neurosci (2015) 0.79
The proteome of schizophrenia. NPJ Schizophr (2015) 0.79
Lamarckian evolution explains human brain evolution and psychiatric disorders. Front Neurosci (2013) 0.78
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment. Genome Med (2013) 0.78
A three step network based approach (TSNBA) to finding disease molecular signature and key regulators: a case study of IL-1 and TNF-alpha stimulated inflammation. PLoS One (2014) 0.77
Making Sense of Blood-Based Proteomics and Metabolomics in Psychiatric Research. Int J Neuropsychopharmacol (2015) 0.76
Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis. PLoS One (2015) 0.76
Simvastatin augmentation for recent-onset psychotic disorder: A study protocol. BBA Clin (2015) 0.75
Proteomics Research in Schizophrenia. Front Cell Neurosci (2016) 0.75
Realising stratified psychiatry using multidimensional signatures and trajectories. J Transl Med (2017) 0.75
Theranostic Biomarkers for Schizophrenia. Int J Mol Sci (2017) 0.75
Regression towards the mean. BMJ (1994) 6.57
Regression to the mean: what it is and how to deal with it. Int J Epidemiol (2004) 6.29
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clin Cancer Res (2011) 2.44
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry (2001) 2.35
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging (2009) 1.77
The STARD initiative. Lancet (2003) 1.57
The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia. Neuropsychopharmacology (2001) 1.48
Identification of a biological signature for schizophrenia in serum. Mol Psychiatry (2011) 1.43
The metabolic syndrome and schizophrenia. Acta Psychiatr Scand (2009) 1.40
Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients. J Clin Psychiatry (2004) 1.39
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomark Insights (2010) 1.30
The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry (1976) 1.25
Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective. Int J Neuropsychopharmacol (2010) 1.25
Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry (2004) 1.21
Relationships between plasma leptin concentrations and human brain structure: a voxel-based morphometric study. Neurosci Lett (2006) 1.12
Antipsychotic-induced weight gain and therapeutic response: a differential association. J Clin Psychopharmacol (2002) 1.10
Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology (2011) 1.07
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients. Mol Psychiatry (2010) 1.05
Personalized medicine--trends in molecular diagnostics: exponential growth expected in the next ten years. Mol Diagn Ther (2011) 1.05
Clozapine-induced weight gain predicts improvement in psychopathology. Schizophr Res (2003) 1.04
Effects of atypical antipsychotics on weight and serum lipid levels. J Clin Psychiatry (2001) 0.98
Modeling treatment-resistant depression. Neuropharmacology (2011) 0.93
Altered levels of acute phase proteins in the plasma of patients with schizophrenia. Anal Chem (2006) 0.93
Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatr Dis Treat (2011) 0.89
Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. Int Heart J (2011) 0.85
Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine. J Korean Med Sci (2008) 0.83
Is leptin the link between obesity and insulin resistance? Diabetes Metab (1997) 0.82
Clinical and biochemical correlates of "high-dose" clozapine therapy for treatment-refractory schizophrenia. Schizophr Res (2001) 0.79
Chart reviews in emergency medicine research: Where are the methods? Ann Emerg Med (1996) 6.95
Analysis of vertebrate SCL loci identifies conserved enhancers. Nat Biotechnol (2000) 4.01
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry (2004) 3.90
Containment, enactment and communication. Int J Psychoanal (2000) 2.81
Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc Natl Acad Sci U S A (1988) 2.63
Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. AJNR Am J Neuroradiol (1992) 2.58
Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord (1999) 2.46
Catalyst design by interpolation in the periodic table: bimetallic ammonia synthesis catalysts. J Am Chem Soc (2001) 2.26
Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J Neurosci (1997) 2.08
[Sadistic fetishism--deadly passion. Forensic psychiatric assessment of sex offenders]. Nervenarzt (2008) 2.02
Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci (1999) 1.90
Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry (2006) 1.80
Gene expression profiling in the adult Down syndrome brain. Genomics (2007) 1.73
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry (1999) 1.61
Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr Res (1998) 1.53
Borna disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders. J Infect Dis (1999) 1.53
Three-dimensional fast low-angle shot imaging and computerized volume measurement of the hippocampus in patients with chronic epilepsy of the temporal lobe. AJNR Am J Neuroradiol (1991) 1.43
Identification of a biological signature for schizophrenia in serum. Mol Psychiatry (2011) 1.43
Distinct 5' SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: neural expression is mediated by GATA factor binding sites. Dev Biol (1999) 1.41
Sex-specific serum biomarker patterns in adults with Asperger's syndrome. Mol Psychiatry (2010) 1.40
[Subjective experience and neuronal integration in the brain: do we need a first-person neuroscience?]. Fortschr Neurol Psychiatr (2006) 1.40
The aim of psychoanalysis in theory and in practice. Int J Psychoanal (1996) 1.38
Atenolol in essential hypertension. Clin Pharmacol Ther (1976) 1.38
Continuing education for the rural physician. JAMA (1979) 1.37
Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry (1985) 1.35
Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family. J Biol Chem (1992) 1.34
Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study. Am J Psychiatry (2000) 1.30
Functional dissociation between medial and lateral prefrontal cortical spatiotemporal activation in negative and positive emotions: a combined fMRI/MEG study. Cereb Cortex (2000) 1.29
Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology (Berl) (1999) 1.28
Transcriptome analysis of male-female differences in prefrontal cortical development. Mol Psychiatry (2009) 1.28
Observing responses and uncertainty reduction. Q J Exp Psychol (1967) 1.25
Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration. Clin Cancer Res (2000) 1.24
Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry (2008) 1.24
Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci (1986) 1.23
Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry (1994) 1.23
Evidence for structural abnormalities of the human habenular complex in affective disorders but not in schizophrenia. Psychol Med (2009) 1.21
Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry (1995) 1.21
A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clin Exp Allergy (2011) 1.16
Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post mortem study. Schizophr Res (1992) 1.12
Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry (1999) 1.12
Effects of methyldopa on prolactin and growth hormone. Br Med J (1976) 1.11
Limbic pathology in schizophrenia: the entorhinal region--a morphometric study. Biol Psychiatry (1988) 1.11
Geographic analysis of pertussis infection in an urban area: a tool for health services planning. Am J Public Health (1997) 1.10
A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry (1983) 1.10
Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci Lett (1999) 1.08
Periodate-induced lymphocyte transformation. IV. Mitogenic effect of NaIO4 treated lymphocytes upon autologous lymphocytes. J Immunol (1974) 1.08
TRransformation of human lymphocytes by sodium periodate. Lancet (1972) 1.08
Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients. Psychiatry Res (1992) 1.07
HIV service provision and training needs in outpatient mental health settings. Psychiatr Q (1999) 1.06
Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Mol Psychiatry (2009) 1.05
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients. Mol Psychiatry (2010) 1.05
The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. Br J Pharmacol (2008) 1.05
The cerebellum: a model system for studying GABAA receptor diversity. Neuropharmacology (1996) 1.05
Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Mol Psychiatry (2004) 1.04
Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis. Allergy (2013) 1.04
Rapid freezing and electron microscopy for the arrest of physiological processes. J Microsc (1974) 1.03
Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study. Schizophr Res (1995) 1.03
Successful treatment of chronic resistant alcoholism by deep brain stimulation of nucleus accumbens: first experience with three cases. Pharmacopsychiatry (2009) 1.02
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues. Mol Psychiatry (2007) 1.02
Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry (2006) 1.02
Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Transl Psychiatry (2012) 1.02
Molecular cloning of mouse pancreatic islet R-cadherin: differential expression in endocrine and exocrine tissue. Mol Endocrinol (1993) 1.01
Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry (1992) 1.00
Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience (1998) 1.00
Cerebellar volume asymmetries are related to handedness: a quantitative MRI study. Neuropsychologia (1995) 0.99
Gliosis in schizophrenia: a survey. Biol Psychiatry (1986) 0.99
Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology (1999) 0.98
Is our self based on reward? Self-relatedness recruits neural activity in the reward system. Neuroimage (2007) 0.97
High field FMRI reveals thalamocortical integration of segregated cognitive and emotional processing in mediodorsal and intralaminar thalamic nuclei. Front Neuroanat (2010) 0.97
Nardilysin in human brain diseases: both friend and foe. Amino Acids (2013) 0.97
Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength. Alcohol Clin Exp Res (1999) 0.97
The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. Allergy (2012) 0.96
Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry (1992) 0.96
Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease? Psychol Med (1997) 0.96
Ethanol, growth hormone and testosterone in peripubertal rats. J Endocrinol (1997) 0.96
The brains of the Vogt collection. Arch Gen Psychiatry (1988) 0.95
The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2. Biochem J (1994) 0.94
Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol (1999) 0.94
Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cogn Disord (2001) 0.94
The T-cell oncogenic protein HOX11 activates Aldh1 expression in NIH 3T3 cells but represses its expression in mouse spleen development. Mol Cell Biol (1998) 0.94
The pathomorphology of schizophrenia and mood disorders: similarities and differences. Schizophr Res (1999) 0.94
Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience (2010) 0.93
Cerebral volume asymmetries in schizophrenia and mood disorders: a quantitative magnetic resonance imaging study. Int J Psychophysiol (1999) 0.93
Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr Res (1995) 0.93
In vivo staining properties of oral cancer. Am J Surg (1965) 0.93
A questionnaire study of risk-taking in psychiatric patients. Br J Med Psychol (1972) 0.92
Elevated S100B levels in schizophrenia are associated with insulin resistance. Mol Psychiatry (2010) 0.92
Effect of chronic ethanol exposure on female rat reproductive cyclicity and hormone secretion. Alcohol Clin Exp Res (2001) 0.92
Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophr Bull (1992) 0.92